Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single and Multiple-Dose, Two-Period, Consecutive Study in Healthy Chinese Subjects to Assess the Pharmacokinetic Profiles, Safety and Tolerability of Lidocaine Patch 5%.LIG13-CN-101 Study

NCT02452112 is registered in ClinicalTrials.gov with Mundipharma (China) Pharmaceutical Co. Ltd as lead sponsor.

NCT NCT02452112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02452112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single and Multiple-Dose, Two-Period, Consecutive Study in Healthy Chinese Subjects to Assess the Pharmacokinetic Profiles, Safety and Tolerability of Lidocaine Patch 5%.LIG13-CN-101 Study
Lead sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Phase
Phase 2/3
Overall status
Completed
Start date
November 2, 2014
Completion date
October 30, 2016
Enrollment
243 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster pain